We read with interest the article by Aeby et al., describing two
girls with epilepsy, large, facial hemangiomas of infancy, cerebral
vascular dysplasia, and supratentorial cortical malformation. [1] The
authors note the uncommon nature of this association, citing two previous
articles in which large facial hemangiomas occurred along with structural
brain and cerebrovascular anomalies.
As noted, the association between large facial hemangiomas and
underlying cervicocranial arterial anomalies was first recognized by
Pascual-Castroviejo in 1978. Subsequently, underlying posterior fossa
brain abnormalities, particularly Dandy-Walker type malformations, were
also found to be strongly associated. [2] In 1995, Frieden et al noted the
association of cardiac, ocular, and ventral developmental anomalies among
children with large facial hemangiomas. [3] The acronym PHACE syndrome was
coined for this constellation of findings and it is now a well-recognized
neurocutaneous syndrome (OMIM 606519). This acronym (sometimes also
called PHACES because of ventral developmental defects) refers to the
associations of large, segmental (h)emangiomas, most commonly of the face,
associated with one or more of the following anomalies: (p)osterior fossa
brain malformations, (a)rterial anomalies, (c)oarctation of the aorta and
(c)ardiac defects, (e)ye abnormalities and ventral developmental defects
including (s)ternal clefting and/or (s)upraumbilical raphe.
In 2001, we published 14 new patients with PHACE syndrome and
reviewed 116 reported cases.[4] In busy pediatric dermatology practices
where we see large numbers of infants with hemangiomas, we see several
cases of PHACE syndrome each year, suggesting that while relatively
unrecognized in the past, it is not an extremely rare neurocutaneous
syndrome. It is important to note that PHACE represents a spectrum of
anomalies, as the majority of affected children have only one
extracutaneous manifestation of the syndrome, most commonly structural or
arterial anomalies of the brain. Although the true incidence is unknown, a
potential for secondary neurologic sequelae, most commonly developmental
delay, seizures, acute hemiparesis or migraine headaches, exists among
patients with underlying brain involvement. An additional risk in such
patients is that of progressive neurovascular disease manifesting as
aneurysm formation and/or arterial stenosis or occlusion, though the
incidence of such complications is also unknown. [4, 5]
PHACE has been postulated to occur from a developmental error or
insult occurring between the sixth and eighth weeks of gestation. Recent
advances in genetics research have pointed to so-called developmental
field defects, which result from errors in morphoregulatory genes that
then lead to a constellation of anomalies in a spatially related,
temporally synchronous manner. PHACE syndrome should be considered in any
infant presenting with a large, plaque-like facial hemangioma, and
children at risk should undergo careful ophthalmologic and cardiac, in
addition to neurologic, evaluation. Long-term outcome data from affected
patients are necessary before further diagnostic and therapeutic
guidelines can be established.
References
1. Aeby A, Guerrini R, David P, et al. Facial hemangioma and cerebral
corticovascular dysplasia: A syndrome associated with epilepsy. Neurology
2003;60:1030-1032.
2. Reese V, Frieden IJ, Paller AS, et al. The association of facial
hemangiomas with Dandy-Walker and other posterior fossa malformations. J
Pediatr 1993;122:379-384.
3. Frieden IJ, Reese V, Cohen D. PHACE syndrome: the association of
posterior fossa brain malformations, hemangiomas, arterial anomalies,
coarctation of the aorta and cardiac defects, and eye abnormalities. Arch
Dermatol 1996;132:307-311.
4. Metry DW, Dowd CF, Barkovich AJ, et al. The many faces of PHACE
syndrome. J Pediatr 2001;139:117-123.
5. Burrows PE, Robertson RL, Mulliken JB, et al. Cerebral
vasculopathy and neurologic sequelae in infants with cervicofacial
hemangioma: report of 8 patients. Radiology 1998;207:601-607.